c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.
Tanaka, Sakae; Amling, Michael; Neff, Lynn; Peyman, Anusch; Uhlmann, Eugen; Levy, Joan B.; Baron, Roland
[Letter]
Nature.
383(6600):528-531, October 10, 1996.
(Format: HTML)
The primary defect in mice lacking the c-src gene is osteopetrosis, a deficiency in bone resorption by osteoclasts [1]. Osteoclasts express high levels of the c-Src protein [2,3] and the defect responsible for the osteopetrotic phenotype of the c-src-deficient (src sup -) mouse is cell-autonomous and occurs in mature osteoclasts [4,5]. However, the specific signalling pathways that require c-Src expression for normal osteoclast activity have not been elucidated. We report here that the proto-oncogene product c-Cbl is tyrosine-phosphorylated in a Src-dependent manner in osteoclasts, where the two proteins colonize on some vesicular structures. In vitro bone resorption by osteoclast-like cells (OCLs) is inhibited by both c-src and c-cbl antisense oligonucleotides. Furthermore, tyrosine phosphorylation of c-Cbl and the localization of c-Cbl-containing structures to the peripheral cytoskeleton are impaired in resorption-deficient c-src sup - OCLs, as well as in wild-type OCLs that have been treated with c-src antisense oligonucleotides. These results indicate that c-Cbl may act downstream of c-Src in a signalling pathway that is required for bone resorption.
(C) 1996 Macmillan Magazines Ltd.